Market Cap: $141.81M
CI
Codexis, Inc.
CDXS
NASDAQ (NASDAQ Global Select)USD
Market Cap: $141.81M
Codexis Reports Strong Financial Results, Signals Growth Potential Codexis Inc. showcases robust performance in its latest earnings announcement, addressing the growing demand for biotechnology soluti…
### Codexis Drives Innovative Solutions in Biomanufacturing Codexis Inc. is at the forefront of biomanufacturing advancements, leveraging its proprietary technology platform to revolutionize enzyme pr…
Codexis Reports Strong Financial Performance, Sparks Investor Optimism Codexis Inc. showcases robust financial results for its 2025 fiscal year, leading to a notable surge in after-hours trading. The…
Codexis Expands RNA Therapeutics Manufacturing Capabilities Codexis, Inc. announces a pivotal agreement to produce 50 grams of small interfering RNA (siRNA) through its advanced ECO Synthesis manufact…
Codexis Accelerates RNA Therapeutics Manufacturing with Innovative Partnership Codexis, Inc. (NASDAQ: CDXS), a frontrunner in enzymatic solutions for therapeutic manufacturing, announces a strategic p…
Codexis Advances RNA Therapeutics with Strategic Manufacturing Agreement Codexis, Inc. announces a significant collaboration aimed at advancing the manufacturing capabilities of small interfering RNA…
Codexis Advances Biocatalysis Solutions for Sustainable Manufacturing Codexis, a leader in enzyme innovation, makes significant strides in biocatalysis, which is crucial for sustainable manufacturing…
Codexis: Leveraging Biocatalysis to Revolutionize Sustainable Manufacturing Codexis, a leader in biocatalysis technology, focuses on developing innovative enzyme solutions that enhance manufacturing p…
Codexis and the Biotech Landscape: Innovations in Enzyme Engineering In the rapidly evolving biotechnology sector, Codexis stands out for its innovative approach to enzyme engineering. The company foc…
Codexis and Nitto Denko Avecia Forge Strategic Partnership for Enhanced Therapeutic Manufacturing Codexis, Inc., a leader in enzymatic solutions for therapeutic manufacturing, announces a significant…
Codexis Partners with Nitto Denko Avecia to Advance Oligonucleotide Therapeutics Codexis, Inc., a frontrunner in enzymatic solutions for therapeutic manufacturing, announces a strategic partnership wi…
Codexis Partners with Nitto Denko Avecia to Advance Oligonucleotide Therapeutics Codexis, Inc., a leader in enzymatic solutions for therapeutic manufacturing, establishes an evaluation agreement with…